On the origin of EDSS

Kendall, 1947, vol. 1, 319

Kurtzke, 1955, A new scale for evaluating disability in multiple sclerosis, Neurology, 5, 580, 10.1212/WNL.5.8.580

Kurtzke, 1956, Course of exacerbations of multiple sclerosis in hospitalized patients, Arch Neurol Psychiatry, 76, 175, 10.1001/archneurpsyc.1956.02330260061002

Kurtzke, 1961, On the evaluation of disability in multiple sclerosis, Neurology, 11, 686, 10.1212/WNL.11.8.686

Kurtzke, 1965, Further notes on disability evaluation in multiple sclerosis, with scale modiications, Neurology, 15, 654, 10.1212/WNL.15.7.654

Kurtzke, 1970, Clinical manifestations of multiple sclerosis, vol. 9, 161

Kurtzke, 1970, Neurologic impairment in multiple sclerosis and the Disability Status Scale, Acta Neurol Scand, 46, 493, 10.1111/j.1600-0404.1970.tb05808.x

Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444

Kurtzke, 1984, Disability rating scales in multiple sclerosis, Ann NY Acad Sci, 436, 347, 10.1111/j.1749-6632.1984.tb14805.x

Kurtzke, 1988, Risk factors, course and prognosis of multiple sclerosis, 87

Kurtzke, 1989, The Disability Status Scale for multiple sclerosis: Apologia pro DSS sua, Neurology, 39, 291, 10.1212/WNL.39.2.291

Kurtzke, 1989, Patterns of neurologic involvement in multiple sclerosis, Neurology, 39, 1235, 10.1212/WNL.39.9.1235

Kurtzke, 2008, Historical and clinical perspectives of the Expanded Disability Status Scale, Neuroepidemiology, 31, 1, 10.1159/000136645

Kurtzke, 1954, The effects of isoniazid on patients with multiple sclerosis. Preliminary report, Am Rev Tuberc, 70, 577

Kurtzke, 1957, Isoniazid in treatment of multiple sclerosis, JAMA, 163, 172, 10.1001/jama.1957.02970380014005

Kurtzke, 1968, Studies on the natural history of multiple sclerosis 4. Clinical features of the onset bout, Acta Neurol Scand, 44, 467, 10.1111/j.1600-0404.1968.tb05587.x

Kurtzke, 1972, Studies on the natural history of multiple sclerosis. 6. Clinical and laboratory findings at first diagnosis, Acta Neurol Scand, 48, 19, 10.1111/j.1600-0404.1972.tb07525.x

Nagler, 1966, Studies on the natural history of multiple sclerosis. 1. Design and diagnosis, Act Neurol Scand, 42, 141

Rose, 1968, Cooperative study in the evaluation of therapy in multiple sclerosis; ACTH vs placebo in acute exacerbations. Preliminary Report, Neurology, 18

Rose, 1970, Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. plcebo. Final Report, Neurology, 20, 1

Schumacher, 1965, Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis, Ann NY Acad Sci, 122, 522, 10.1111/j.1749-6632.1965.tb20235.x

Veterans Administration Multiple Sclerosis Study Group, 1957, Isoniazid in treatment of multiple sclerosis. Report on Veterans Administration Cooperative Study, JAMA, 163, 168, 10.1001/jama.1957.02970380010004